Atlas Trials

MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial

Clinical trial NCT03892785 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03892785
Sponsor
Centre Hospitalier Universitaire Dijon
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Giant Cell Arteritis
Start date
2020-01-27
Primary completion
2027-01-01
Enrollment
230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.